Detalhe da pesquisa
1.
Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma.
BMC Cancer
; 24(1): 387, 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539150
2.
Nomograms combining computed tomography-based body composition changes with clinical prognostic factors to predict survival in locally advanced cervical cancer patients.
J Xray Sci Technol
; 32(2): 427-441, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38189735
3.
Body composition predicts prognosis of hepatocellular carcinoma patients undergoing immune checkpoint inhibitors.
J Cancer Res Clin Oncol
; 149(13): 11607-11617, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37400572